1. Home
  2. WAFD vs ZLAB Comparison

WAFD vs ZLAB Comparison

Compare WAFD & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WaFd Inc.

WAFD

WaFd Inc.

HOLD

Current Price

$36.29

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

N/A

Current Price

$26.25

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WAFD
ZLAB
Founded
1917
2013
Country
United States
China
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.6B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
WAFD
ZLAB
Price
$36.29
$26.25
Analyst Decision
Hold
Strong Buy
Analyst Count
4
5
Target Price
$35.00
$49.60
AVG Volume (30 Days)
406.7K
1.3M
Earning Date
04-16-2026
05-07-2026
Dividend Yield
3.08%
N/A
EPS Growth
5.20
38.46
EPS
2.45
N/A
Revenue
$29,650,000.00
$460,156,000.00
Revenue This Year
N/A
$9.75
Revenue Next Year
$4.15
$26.03
P/E Ratio
$14.71
N/A
Revenue Growth
7.79
15.33
52 Week Low
$26.31
$15.96
52 Week High
$39.49
$34.72

Technical Indicators

Market Signals
Indicator
WAFD
ZLAB
Relative Strength Index (RSI) 41.39 67.47
Support Level $34.18 $16.84
Resistance Level $36.12 $27.08
Average True Range (ATR) 0.55 0.87
MACD -0.10 -0.13
Stochastic Oscillator 27.12 84.97

Price Performance

Historical Comparison
WAFD
ZLAB

About WAFD WaFd Inc.

WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: